17,251 Shares in Ventas, Inc. $VTR Purchased by Union Bancaire Privee UBP SA

Union Bancaire Privee UBP SA purchased a new stake in Ventas, Inc. (NYSE:VTRFree Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 17,251 shares of the real estate investment trust’s stock, valued at approximately $1,335,000.

Several other large investors also recently made changes to their positions in VTR. Vanguard Group Inc. raised its holdings in shares of Ventas by 2.5% in the 3rd quarter. Vanguard Group Inc. now owns 73,598,827 shares of the real estate investment trust’s stock worth $5,151,182,000 after purchasing an additional 1,802,515 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in Ventas by 1.3% during the third quarter. JPMorgan Chase & Co. now owns 29,701,300 shares of the real estate investment trust’s stock worth $2,078,794,000 after buying an additional 387,495 shares in the last quarter. State Street Corp grew its position in Ventas by 3.3% in the third quarter. State Street Corp now owns 28,927,015 shares of the real estate investment trust’s stock worth $2,038,176,000 after buying an additional 928,386 shares during the last quarter. Dimensional Fund Advisors LP grew its position in Ventas by 2.5% in the third quarter. Dimensional Fund Advisors LP now owns 6,601,143 shares of the real estate investment trust’s stock worth $462,002,000 after buying an additional 160,998 shares during the last quarter. Finally, Northern Trust Corp increased its holdings in shares of Ventas by 1.7% in the third quarter. Northern Trust Corp now owns 6,402,941 shares of the real estate investment trust’s stock valued at $448,142,000 after buying an additional 108,990 shares in the last quarter. Institutional investors own 94.18% of the company’s stock.

Insider Activity

In related news, CFO Robert F. Probst sold 29,930 shares of the stock in a transaction on Friday, January 2nd. The stock was sold at an average price of $77.25, for a total transaction of $2,312,092.50. Following the completion of the sale, the chief financial officer directly owned 138,434 shares in the company, valued at approximately $10,694,026.50. This trade represents a 17.78% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Debra A. Cafaro sold 10,322 shares of Ventas stock in a transaction on Monday, February 2nd. The shares were sold at an average price of $77.66, for a total value of $801,606.52. Following the sale, the chief executive officer directly owned 1,114,034 shares of the company’s stock, valued at approximately $86,515,880.44. The trade was a 0.92% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 86,106 shares of company stock worth $6,931,397 in the last ninety days. Corporate insiders own 0.80% of the company’s stock.

Ventas Price Performance

Shares of VTR opened at $82.46 on Friday. The business’s 50-day moving average is $82.51 and its 200-day moving average is $77.03. The company has a debt-to-equity ratio of 1.03, a current ratio of 0.67 and a quick ratio of 0.67. The company has a market capitalization of $39.16 billion, a price-to-earnings ratio of 152.70, a P/E/G ratio of 2.04 and a beta of 0.73. Ventas, Inc. has a fifty-two week low of $60.15 and a fifty-two week high of $88.36.

Ventas (NYSE:VTRGet Free Report) last posted its quarterly earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 EPS for the quarter, missing the consensus estimate of $0.89 by ($0.74). Ventas had a return on equity of 2.09% and a net margin of 4.31%.The company had revenue of ($1,229.71) million for the quarter, compared to analyst estimates of $1.53 billion. During the same quarter in the prior year, the business posted $0.81 earnings per share. The business’s revenue for the quarter was up 21.7% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Equities research analysts expect that Ventas, Inc. will post 3.4 EPS for the current fiscal year.

Ventas Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, April 16th. Shareholders of record on Tuesday, March 31st will be paid a dividend of $0.52 per share. This is an increase from Ventas’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. Ventas’s dividend payout ratio (DPR) is 355.56%.

Wall Street Analysts Forecast Growth

VTR has been the subject of a number of recent research reports. Morgan Stanley set a $90.00 price objective on Ventas in a research report on Friday, February 13th. Royal Bank Of Canada lifted their target price on Ventas from $83.00 to $91.00 and gave the stock an “outperform” rating in a report on Tuesday, February 10th. UBS Group reaffirmed a “neutral” rating and set a $85.00 target price on shares of Ventas in a report on Monday, February 9th. KeyCorp increased their price target on Ventas from $85.00 to $90.00 and gave the company an “overweight” rating in a research report on Tuesday, February 10th. Finally, Argus set a $88.00 price target on Ventas in a research note on Tuesday, February 10th. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $90.13.

Check Out Our Latest Analysis on VTR

Ventas Profile

(Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.

See Also

Institutional Ownership by Quarter for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.